Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

Mouse Anti-COL4A3 Recombinant Antibody (CBCNC-272) (CBMAB-C2633-CN)

This product is a Mouse antibody that recognizes COL4A3. The antibody CBCNC-272 can be used for immunoassay techniques such as: WB, ICC, IHC-P, IHC-F, ELISA.
Host Species
Mouse
Application
WB, ICC, IHC-P, IHC-F, ELISA
Immunogen
Collagen Type IV Alpha 3
Specificity
Human
Clone
CBCNC-272
Introduction
COL4A3 (Collagen Type IV Alpha 3 Chain) is a Protein Coding gene. Diseases associated with COL4A3 include Alport Syndrome, Autosomal Dominant and Hematuria, Benign Familial. Among its related pathways are Primary Focal Segmental Glomerulosclerosis FSGS and Integrin Pathway. Gene Ontology (GO) annotations related to this gene include structural molecule activity and extracellular matrix structural constituent. An important paralog of this gene is COL4A5.
Alternative Name
Collagen Type IV Alpha 3 Chain; Collagen, Type IV, Alpha 3 (Goodpasture Antigen); Tumstatin; Collagen IV, Alpha-3 Polypeptide; Collagen Alpha-3(IV) Chain; Goodpasture Antigen;
Entrez Gene ID
UniProt ID
Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Submit a review Submit a review and you will get a coupon.
0 reviews
Loading...

Please try the standard protocols which include: protocols, troubleshooting and guide.

Click here to view the protocols, troubleshooting and guide.

Cat CBMAB-C2633-CN
Conjugates
Size
Price $
  ADD TO CART
Request bulk or custom quote
Second antibody and isotype control